“We thought if we can see an immune response in patients with cancer, the vaccine should work even better in people who are at higher risk because of a family history, gene alteration or cyst on the pancreas,”

Neeha Zaidi · said date not stated · reported 2026-07-17

Zaidi explains the rationale for testing the vaccine in high-risk individuals after seeing immune responses in cancer patients.